- Technology that improves bio-absorption and bio-availability
- Bioactive compound delivery system with application across a range of drugs
- Revenue streams from out-licensing
The word in culinary circles is that where there is fat, there is flavor. That’s because fats (there are several different kinds) have a matchless ability to absorb and preserve flavors. Fats belong to a class of compounds called lipids, which the human digestive system absorbs remarkably efficiently. This characteristic makes them ideal for pairing with hard to digest remedials and tonics. Taking a leaf, perhaps, from haute cuisine, this is exactly what Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is doing. The innovative biotech has developed a lipid-based system that delivers bioactive compounds more efficiently. The patented proprietary technology, which the company plans to out-license, not only augments bio-absorption and bioavailability but also improves taste, smell and onset of action.
Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of lipids. Lipids seem a natural choice, since the human endocannabinoid system is itself lipid-based. Using them as a vehicle for delivering cannabinoids in curatives results in more absorption, less waste and, just as importantly, fewer side effects (http://nnw.fm/7Yuym). With DehydraTECH, a little hemp oil goes a long way, improving the healthful benefits and, of course, saving money.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer